Home/Filings/4/0000950170-23-065955
4//SEC Filing

Wood David S. 4

Accession 0000950170-23-065955

CIK 0001633932other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 11:11 AM ET

Size

5.2 KB

Accession

0000950170-23-065955

Insider Transaction Report

Form 4
Period: 2023-10-24
Wood David S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-24+3,7503,750 total
    Exercise: $3.91Exp: 2033-10-24Common Shares (3,750 underlying)
Footnotes (1)
  • [F1]25% of the options vest after 12 months from the date of grant. 75% vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month thereafter.

Documents

1 file

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1
  • filerCIK 0001826902

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 11:11 AM ET
Size
5.2 KB